Life Insurance Corporation of India (LIC) IPO Review

About the Company

If your parents or grandparents own a life insurance policy in India, there's a very good chance it's an LIC one. For nearly 70 years, LIC has been the default name in Indian life insurance so dominant that for most families, "insurance" simply meant LIC.

Founded in 1956, the Life Insurance Corporation of India is the country's largest life insurer by a huge margin, holding around 66% of new business premium. It's still majority government-owned, with the state holding about 96.5%.

LIC sells the full range of life products term cover, endowment and money-back plans, ULIPs, pensions, annuities and group schemes through an army of over 13 lakh agents plus banks and digital channels. It makes money on the premiums it collects and, crucially, on the enormous investment book it runs; LIC is the single largest institutional investor in Indian markets, with total assets above ₹53 lakh crore. It's less a company than a financial institution woven into the country. Track its live price and listing data on the IPO GMP Live homepage.

Financial Snapshot

Let's start with the uncomfortable truth for IPO investors. LIC listed at ₹872 in May 2022, already below its ₹949 issue price, and four years later the stock trades around ₹440 — still roughly 54% below where it was sold. As India's largest-ever IPO at the time, it has been one of the most disappointing for those who applied.

The business itself is enormous and profitable. LIC reported consolidated net profit of about ₹57,453 crore in FY26, up roughly 19%, on premium income running into lakhs of crores, and it pays a healthy dividend ₹10 a share for FY26. Return on equity has averaged around 45% over three years. These are not the numbers of a struggling company.

So why has the stock lagged? Two reasons. The IPO was priced richly, leaving little upside. And LIC keeps slowly losing market share to nimbler private insurers, even as it stays the giant.

The flip side is valuation. LIC trades cheaply at a fraction of the multiples private insurers like HDFC Life and SBI Life command. For value investors, that's the appeal. The debate is whether it's genuinely cheap, or a value trap that stays cheap.

Strengths

• Its dominance is unmatched. LIC holds around 66% of India's new business premium and is rated the world's third-strongest insurance brand. That scale, trust and distribution moat over 13 lakh agents can't be replicated by any rival.
• It's hugely profitable and pays out. Consolidated net profit was about ₹57,453 crore in FY26, return on equity has averaged near 45% over three years, and it declared a ₹10 per share dividend. The cash generation is enormous and real.
• The valuation is genuinely cheap. LIC trades at a small fraction of the multiples private insurers command. For investors hunting value among large, profitable companies, that low rating is the core attraction.
• There's hidden value too. As India's largest institutional investor with assets above ₹53 lakh crore, LIC also owns 10.72% of the NSE and with the NSE itself heading for an IPO, that stake could unlock meaningful value.

Risks

• It's been a poor IPO. From a ₹949 issue price, the stock now sits near ₹440 roughly 54% lower four years on. Whatever the business does, the share simply hasn't rewarded those who bought at listing.
• Market share keeps slipping. Private insurers continue to chip away at LIC's lead, and its growth is slow. Being the giant doesn't help if the giant is gradually losing ground.
• The government overhang is real. The state still owns about 96.5%, and further stake sales are expected as the government looks to raise money. That steady supply of shares caps how far the price can run.
• It may be a value trap. Cheap is only useful if something re-rates it, and LIC has stayed cheap for years without a catalyst. The low valuation could persist rather than correct.

Should You Buy, Hold, or Sell?

Four years on, this is a call on a cheap, dominant, but chronically underperforming stock at around ₹440 still well below its ₹949 issue price.

Conservative investors — there's an income case here. The dividend and dominant franchise suit a patient, low-expectation holding, but accept the stock may stay cheap for a long time.

Moderate investors — hold if you own it; for fresh money, the low valuation and NSE-stake angle offer a value play, but size it small and be patient.

Aggressive investors — there's little momentum here, so it's not a quick trade. The only fast catalyst would be value unlock from its NSE stake or a re-rating that's been elusive for years.

Honest take: a dominant, cheap, dividend-paying giant that has frustrated shareholders for four years a value play for the patient, not a stock for those chasing quick returns.

IPO Objects of the Issue

This was a 100% offer-for-sale by the Government of India, the largest IPO in India at the time. The company received no proceeds — the entire amount went to the government, which sold a 3.5% stake.

Contact Details

Life Insurance Corporation of India (LIC) Yogakshema Building, Jeevan Bima Marg, Nariman Point, Mumbai – 400021, Maharashtra 🌐 www.licindia.in

IPO Registrar — KFin Technologies Ltd. 📞 040-6716 2222 / 040-7961 1000 📧 einward.ris@kfintech.com 🌐 www.kfintech.com

Related IPO reviews: HDB Financial Services IPO · Tata Capital IPO · Bajaj Housing Finance IPO · Hyundai Motor India IPO · Meesho IPO · Lenskart IPO · Zepto IPO · Vahh Chemicals IPO

This page is not investment advice. GMP is indicative only. Please consult a SEBI-registered financial advisor before investing.